Dr Chunling Huang
People_

Dr Chunling Huang

NHMRC Early Career Fellow
Senior Research Fellow
Northern Clinical School
Faculty of Medicine and Health

Publications

Journals

  • Cao, Q., Huang, C., Yi, H., Gill, A., Chou, A., Foley, M., Hosking, C., Lim, K., Triffon, C., Shi, Y., Chen, X., Pollock, C. (2022). A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4. JCI Insight, 7(4), e143018. [More Information]
  • Bian, J., Liebert, A., Bicknell, B., Chen, X., Huang, C., Pollock, C. (2022). Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients, 14(12). [More Information]
  • Huang, C., Chen, X., Pollock, C. (2022). KCa3.1 in diabetic kidney disease. Current Opinion In Nephrology And Hypertension, 31(1), 129-134. [More Information]

2022

  • Cao, Q., Huang, C., Yi, H., Gill, A., Chou, A., Foley, M., Hosking, C., Lim, K., Triffon, C., Shi, Y., Chen, X., Pollock, C. (2022). A single-domain i-body, AD-114, attenuates renal fibrosis through blockade of CXCR4. JCI Insight, 7(4), e143018. [More Information]
  • Bian, J., Liebert, A., Bicknell, B., Chen, X., Huang, C., Pollock, C. (2022). Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients, 14(12). [More Information]
  • Huang, C., Chen, X., Pollock, C. (2022). KCa3.1 in diabetic kidney disease. Current Opinion In Nephrology And Hypertension, 31(1), 129-134. [More Information]

2021

  • Klionsky, D., Kamal Abdel-Aziz, A., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M., Abudu, Y., et al, Al-Akra, L., Bae, D., Dharmasivam, M., Huang, M., Kalinowski, D., Richardson, D., Chen, X., Hesselson, D., Huang, C., Leck, L., Stefan, S., Nguyen, L., Sahni, S., Sue, C., Zheng, G. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1), 1-382. [More Information]
  • Huang, C., Yi, H., Shi, Y., Cao, Q., Shi, Y., Cheng, D., Braet, F., Chen, X., Pollock, C. (2021). KCa3.1 Mediates Dysregulation of Mitochondrial Quality Control in Diabetic Kidney Disease. Frontiers in Cell and Developmental Biology, 9, 573814. [More Information]
  • Yi, H., Huang, C., Shi, Y., Cao, Q., Chen, J., Chen, X., Pollock, C. (2021). Metformin Attenuates Renal Fibrosis in a Mouse Model of Adenine-Induced Renal Injury Through Inhibiting TGF-beta1 Signaling Pathways. Frontiers in Cell and Developmental Biology, 9, 603802. [More Information]

2020

  • Shi, Y., Huang, C., Yi, H., Cao, Q., Zhao, Y., Chen, J., Chen, X., Pollock, C. (2020). RIPK3 blockade attenuates kidney fibrosis in a folic acid model of renal injury. The FASEB Journal, 34(8), 10286-10298. [More Information]
  • Shi, Y., Huang, C., Zhao, Y., Cao, Q., Yi, H., Chen, X., Pollock, C. (2020). RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy. Scientific Reports, 10(1), 10458. [More Information]
  • Shi, Y., Chen, X., Huang, C., Pollock, C. (2020). RIPK3: A New Player in Renal Fibrosis. Frontiers in Cell and Developmental Biology, 8, 502. [More Information]

2019

  • Cao, Q., Chen, X., Huang, C., Pollock, C. (2019). MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: An update. FASEB BioAdvances, 1(6), 375-388. [More Information]

2018

  • Yi, H., Huang, C., Shi, Y., Cao, Q., Zhao, Y., Zhang, L., Chen, J., Pollock, C., Chen, X. (2018). Metformin attenuates folic-acid induced renal fibrosis in mice. Journal of Cellular Physiology, 233(9), 7045-7054. [More Information]
  • Huang, C., Zhang, L., Shi, Y., Yi, H., Zhao, Y., Chen, J., Pollock, C., Chen, X. (2018). The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy. PloS One, 13(2), 1-15. [More Information]

2016

  • Huang, C., Lin, Z., Cheng, D., Braet, F., Pollock, C., Chen, X. (2016). KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways. Scientific Reports, 6, 1-12. [More Information]
  • Peeters, M., Huang, C., Vonk, L., Lu, Z., Bank, R., Helder, M., Doulabi, B. (2016). Optimisation of high-quality total ribonucleic acid isolation from cartilaginous tissues for real-time polymerase chain reaction analysis. Bone & Joint Research, 5(11), 560-568. [More Information]
  • Huang, C., Zhang, Y., Kelly, D., Tan, C., Gill, A., Cheng, D., Braet, F., Park, J., Sue, C., Pollock, C., Chen, X. (2016). Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway. Scientific Reports, 6, 1-13. [More Information]

2015

  • Huang, C., Pollock, C., Chen, X. (2015). KCa3.1: a new player in progressive kidney disease. Current Opinion In Nephrology And Hypertension, 24(1), 61-66. [More Information]

2014

  • Huang, C., Pollock, C., Chen, X. (2014). High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel. PloS One, 9(4), 1-8. [More Information]
  • Huang, C., Day, M., Poronnik, P., Pollock, C., Chen, X. (2014). Inhibition of KCa3.1 suppresses TGF-Beta1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways. International Journal of Biochemistry and Cell Biology, 47(1), 1-10. [More Information]
  • Gangadharan Komala, M., Gross, S., Mudaliar, H., Huang, C., Pegg, K., Mather, A., Shen, S., Pollock, C., Panchapakesan, U. (2014). Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice. PloS One, 9(11), 1-12. [More Information]

2013

  • Huang, C., Shen, S., Ma, Q., Chen, J., Gill, A., Pollock, C., Chen, X. (2013). Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice. Diabetes, 62(8), 2923-2934. [More Information]

Selected Grants

2022

  • Promoting the positive side of kidney fibroblasts to prevent and cure diabetic kidney disease, Chen X, Pollock C, Huang C, Juvenile Diabetes Research Foundation International (JDRF)/Innovative Grant (INO)

2019

  • PTEN-induced putative kinase 1 in renal fibrosis, Huang C, Faculty of Medicine and Health/Ignition Seed Fund Grant